![Howard Lossing](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Howard Lossing
Amministratore Delegato presso Ajinomoto Cambrooke, Inc.
Posizioni attive di Howard Lossing
Società | Posizione | Inizio | Fine |
---|---|---|---|
Ajinomoto Cambrooke, Inc.
![]() Ajinomoto Cambrooke, Inc. Pharmaceuticals: OtherHealth Technology Ajinomoto Cambrooke, Inc. operates as a therapeutic nutrition company. It offers Glytactin with GMP to help meet the nutritional needs of patients with Phenylketonuria; Tylactin with GMP to help meet the nutritional needs of patients with Tyrosinemia; amino acid formulas for the dietary management of disorders of amino acid metabolism; low protein food; KetoVie, ketogenic formulas for the dietary management of intractable epilepsy; and KetoVie Café Food low-carbohydrate ketogenic food for individuals following the spectrum of ketogenic diets. The company was founded by David Paolella and Lynn Paolella in 2000 and is headquartered in Ayer, MA. | Direttore/Membro del Consiglio | - | - |
Amministratore Delegato | - | - | |
Nemysis Ltd.
![]() Nemysis Ltd. BiotechnologyHealth Technology Nemysis Ltd. provides IP platform for medical treatments. It engages in the development of portfolio of IP protected, science-based compounds and products. The company was founded on October 21, 2005 and is headquartered in Dublin, Ireland. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Howard Lossing
Statistiche
Distribuzione geografica
Stati Uniti | 2 |
Irlanda | 2 |
Posizioni
Director/Board Member | 2 |
Chief Executive Officer | 1 |
Settori
Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Ajinomoto Cambrooke, Inc.
![]() Ajinomoto Cambrooke, Inc. Pharmaceuticals: OtherHealth Technology Ajinomoto Cambrooke, Inc. operates as a therapeutic nutrition company. It offers Glytactin with GMP to help meet the nutritional needs of patients with Phenylketonuria; Tylactin with GMP to help meet the nutritional needs of patients with Tyrosinemia; amino acid formulas for the dietary management of disorders of amino acid metabolism; low protein food; KetoVie, ketogenic formulas for the dietary management of intractable epilepsy; and KetoVie Café Food low-carbohydrate ketogenic food for individuals following the spectrum of ketogenic diets. The company was founded by David Paolella and Lynn Paolella in 2000 and is headquartered in Ayer, MA. | Health Technology |
Nemysis Ltd.
![]() Nemysis Ltd. BiotechnologyHealth Technology Nemysis Ltd. provides IP platform for medical treatments. It engages in the development of portfolio of IP protected, science-based compounds and products. The company was founded on October 21, 2005 and is headquartered in Dublin, Ireland. | Health Technology |
- Borsa valori
- Insiders
- Howard Lossing
- Esperienza